Paraoxonase and superoxide dismutase gene polymorphisms and noise-induced hearing loss

被引:86
作者
Fortunato, G
Marciano, E
Zarrilli, F
Mazzaccara, C
Intrieri, M
Calcagno, G
Vitale, DF
La Manna, P
Saulino, C
Marcelli, V
Sacchetti, L
机构
[1] Univ Naples Federico II, Dipartimento Biochim & Biotecnol Med, I-80131 Naples, Italy
[2] CEINGE Scarl, Naples, Italy
[3] Univ Naples Federico II, Dipartimento Neurosci & Sci Comportamento, I-80131 Naples, Italy
[4] Univ Molise, Fac Sci MM FF NN, Dipartimento Sci & Tecnol Ambiente & Territorio, Isernia, Italy
[5] IRCCS Ist Campo Telese, Fdn Salvatore Maugeri, Benevento, Italy
[6] Alenia Aereonatu, Stabilimento Pomigliano Arco, Naples, Italy
关键词
D O I
10.1373/clinchem.2004.037788
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 [基础医学];
摘要
Background: Noise-induced cochlear epithelium damage can cause hearing loss in industrial workers. In experimental systems, noise induces the release of free radicals and may damage the cochlear sensorial epithelium. Therefore, genes involved in regulating the reactive oxygen species manganese-superoxide dismutase (SOD2) and the antioxidant paraoxonase (PON) could influence cochlea vulnerability to noise. We evaluated whether susceptibility to noise-induced hearing loss (NIHL) is associated with SOD2, PON1, and PON2 polymorphisms in workers exposed to prolonged loud noise. Methods: We enrolled 94 male workers from an aircraft factory in the study. The SOD2 gene Was screened by denaturing reversed-phase. HPLC, and the PON1 (Q192R and M55L) and PON2 (S311C) polymorphisms were analyzed by PCR amplification followed by digestion with restriction endonucleases. Results: Three known (A16V, IVS3-23T/G, and IVS3-60T/G) and two new SOD2 polymorphisms (IVS1+8A/G and IVS3+107T/A) were identified. Regression analysis showed that PON2 (SC+CC) [odds ratio (OR)=5.01; 95% confidence interval (CI), 1.11-22.54], SOD2 IVS3-23T/G and IVS3-60T/G (OR=5.09; 95% CI, 1.27-20.47), age (OR=1.22; 95% CI, 1.09-1.36), and smoking (OR = 49.49; 95% CI, 5.09-480.66) were associated with NIHL. No association was detected for PON1 (QQ+RR) and PON1 (LL) genotypes. Conclusions: Our data suggest that SOD2 and PON2 polymorphisms, by exerting variable local tissue antioxidant roles, could predispose to NIHL. However, caution should be exercised in interpreting these data given the small sample size and the difficulty in matching cases to controls regarding the overwhelming risk factor, i.e., smoking at least 10 cigarettes/day. (C) 2004 American Association for Clinical Chemistry.
引用
收藏
页码:2012 / 2018
页数:7
相关论文
共 38 条
[1]
Paraoxonase 1 Met-Leu 54 polymorphism is associated with Parkinson's disease [J].
Akhmedova, SN ;
Yakimovsky, AK ;
Schwartz, EI .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2001, 184 (02) :179-182
[2]
Ambrosone CB, 1999, CANCER RES, V59, P602
[3]
[Anonymous], 1989, MOL CLONING LAB MANU
[4]
BARONE JA, 1987, J OCCUP ENVIRON MED, V29, P741
[5]
Identification of paraoxonase 3 gene (PON3) missense mutations in a population of southern Italy [J].
Campo, S ;
Sardo, AM ;
Campo, GM ;
Avenoso, A ;
Castaldo, M ;
D'Ascola, A ;
Giunta, E ;
Calatroni, A ;
Saitta, A .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2004, 546 (1-2) :75-80
[6]
Further evidence for an association of the paraoxonase 1 (PON1) Met-54 allele with Parkinson's disease [J].
Carmine, A ;
Buervenich, S ;
Sydow, O ;
Anvret, M ;
Olson, L .
MOVEMENT DISORDERS, 2002, 17 (04) :764-766
[7]
Association between the severity of angiographic coronary artery disease and paraoxonase gene polymorphisms in the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) study [J].
Chen, Q ;
Reis, SE ;
Kammerer, CM ;
McNamara, DM ;
Holubkov, R ;
Sharaf, BL ;
Sopko, G ;
Pauly, DF ;
Merz, CNB ;
Kamboh, MI .
AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (01) :13-22
[8]
Nomenclature for the description of human sequence variations [J].
den Dunnen, JT ;
Antonarakis, E .
HUMAN GENETICS, 2001, 109 (01) :121-124
[9]
Identification of 167 polymorphisms in 88 genes from candidate neurodegeneration pathways [J].
Emahazion, T ;
Jobs, M ;
Howell, WM ;
Siegfried, M ;
Wyöni, PI ;
Prince, JA ;
Brookes, AJ .
GENE, 1999, 238 (02) :315-324
[10]
Genetic polymorphisms of superoxide dismutase in Parkinson's disease [J].
Farin, FM ;
Hitosis, Y ;
Hallagan, SE ;
Kushleika, J ;
Woods, JS ;
Janssen, PS ;
Smith-Weller, T ;
Franklin, GM ;
Swanson, PD ;
Checkoway, H .
MOVEMENT DISORDERS, 2001, 16 (04) :705-707